Effectiveness and safety of rituximab-pvvr versus originator rituximab for rheumatoid arthritis in the veterans health administration
Related Posts
Loveless J, Pilcher L, Bolton CJ, Guan DX, Imo U, Ngubo CGA, McAteer MB, Urquhart O, Rangarajan SK, Kim LS, Sako K, Tang B, Yakoub[...]
Sarkisian CA, Villaflores CW, Vangala SS, Cheng EM, Shu SB, Goldstein NJ, Hofer IS, Duval VF, Bartlett JD, Moore JM, Pessegueiro AM, Skootsky SA, Damberg[...]
Le B, Simon W, Zhang J, Robertson J, Dowling E. Collaborative Solutions to Identify Scheduling Barriers for Timely Post-Hospital Discharge Primary Care Follow-Up: A Quality[...]